Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 2108

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 15
Chunk 2108
---
 not material
and (ii) information that the Registrant treats as private or confidential. Denali Capital Acquisition Corp. hereby undertakes to furnish
supplemental copies of the unredacted exhibit upon request by the SEC.

(1)Filed
as an exhibit to Amendment No. 1 to the Registration Statement on Form S-1 filed with the SEC on March 22, 2022 (File No. 333-263123).

(2)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on April 12, 2022 (File No. 001-41351).

(3)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on October 11, 2023 (File No. 001-41351).

(4)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on April 12, 2023 (File No. 001-41351).

(5)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on July 13, 2023 (File No. 001-41351).

(6)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on November 20, 2023 (File No. 001-41351).

(7)Filed
as an exhibit to the Annual Report on Form 10-K filed with the SEC on March 17, 2023 (File No.001-41351).

(8)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on July 10, 2024 (File No. 001-41351).

(9)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on September 5, 2024 (File No. 001-41351).

(10)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on August 9, 2024 (File No. 001-41351).

(11)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on June 27, 2024 (File No. 001-41351).

(12)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on July 17, 2024 (File No